Arcadia, CA, United States of America

Bijay K Pal


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 151(Granted Patents)


Company Filing History:


Years Active: 1997-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bijay K Pal

Introduction

Bijay K Pal is a notable inventor based in Arcadia, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic interventions against viral infections. With a total of 4 patents to his name, his work has the potential to impact public health positively.

Latest Patents

One of Bijay K Pal's latest patents focuses on the potent inhibition of the influenza virus through specifically designed short interfering RNA (siRNA). This patent application discloses siRNA sequences targeting the constant region of the influenza virus nucleoprotein gene. These sequences are designed to inhibit the influenza virus in animals, including humans. The invention includes various forms of the siRNA sequences, such as an aqueous suspension suitable for nasal inhalation and a plasmid that expresses intracellularly in animals. Additionally, the invention encompasses an AAV vector that can establish a permanent inhibitory effect against the influenza virus by integrating into the cellular chromosome of animals. The administration of these siRNA sequences in a therapeutically effective amount is also a key aspect of this invention.

Career Highlights

Throughout his career, Bijay K Pal has worked with reputable organizations, including the Cal Poly Pomona Foundation, Inc. and City of Hope. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of Bijay K Pal's notable coworkers include Lynn M Tran and R Bruce Wallace. Their collaborative efforts have likely enhanced the quality and impact of their research endeavors.

Conclusion

Bijay K Pal's innovative work in the field of biotechnology, particularly in developing siRNA therapies against influenza, showcases his commitment to advancing medical science. His contributions are poised to make a significant difference in the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…